Next Article in Journal
Real-World Outcomes of Selective RET Inhibitor Selpercatinib in the United States: Descriptive, Retrospective Findings from Two Databases
Previous Article in Journal
Validation of the Scottish Inflammatory Prognostic Score (SIPS) in NSCLC Patients Treated with First-Line Pembrolizumab
Previous Article in Special Issue
Optimizing ctDNA: An Updated Review of a Promising Clinical Tool for the Management of Uveal Melanoma
 
 
Communication

Article Versions Notes

Cancers 2024, 16(22), 3834; https://doi.org/10.3390/cancers16223834
Action Date Notes Link
article xml file uploaded 14 November 2024 16:21 CET Original file -
article xml uploaded. 14 November 2024 16:21 CET Update -
article pdf uploaded. 14 November 2024 16:21 CET Version of Record https://www.mdpi.com/2072-6694/16/22/3834/pdf-vor
article html file updated 14 November 2024 16:23 CET Original file -
article xml file uploaded 15 November 2024 09:53 CET Update -
article xml uploaded. 15 November 2024 09:53 CET Update https://www.mdpi.com/2072-6694/16/22/3834/xml
article pdf uploaded. 15 November 2024 09:53 CET Updated version of record https://www.mdpi.com/2072-6694/16/22/3834/pdf
article html file updated 15 November 2024 09:55 CET Update https://www.mdpi.com/2072-6694/16/22/3834/html
Back to TopTop